Freight rates hiked for coal, cement, iron & steel; Nifty below 8,700

The 30-share Sensex was down 256 points at 28,752 and the 50-share Nifty was down 73 points at 8,694

SI Reporter Mumbai
Last Updated : Feb 26 2015 | 1:59 PM IST
Benchmark indices have extended losses as traders remain unimpressed by Railways Minister Suresh Prabhu's plans of reviving Indian Railways after he kept the heavily subsidised fares unchanged and raised freight rates for transportation of coal, cement and iron and steel

Read our full coverage on Union Budget


At 01:40PM, the 30-share Sensex was down 256 points at 28,752 and the 50-share Nifty was down 73 points at 8,694.

Also Read

Click here to track rail stocks
 
In the broader market, both the BSE Midcap index and Smallcap indices, down 0.3% and 0.2% each have performed worse than the front-liners. Market breadth in BSE ended negative with 1,452 declines against 1,031 advances.   
 
Presenting Railways Budget in the Parliament today, Railways Minister Suresh Prabhu flagged lack of adequate investments in railways leading to hiccups in capacity augmentation. He emphasised the need of collaborating with foreign partners to gain access to cutting-edge technology and finance necessary to revitalize the Indian Railways. The Minister also talked about the potential of public-private partnership to improve financial efficiency and performance of Indian railways.

Meanwhile, foreign portfolio investors (FPIs) bought shares worth a net Rs 516.06 crore yesterday, as per provisional data. Domestic institutional investors (DIIs) bought shares worth a net Rs 19.70 crore yesterday, as per provisional data.

Buzzing Stocks
 
All the 12 sectoral indices of BSE are in red. BSE Healthcare index, down 0.8% is the top loser followed by BSE FMCG and Consumer Durables indices losing around 0.7% each.
 
HDFC has gained nearly 2% and ICICI Bank is up 0.3%. However, on the losing side SBI, Axis Bank and HDFC Bank have lost between 0.4% and 0.6% each.
 
Among index heavyweights, Infosys and ITC have shed over 1% while among pharma stocks Sun Pharma is down 2% and Dr Reddys Lab and Cipla have lost around 0.3% each.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 26 2015 | 1:40 PM IST

Next Story